Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Triple Negative Breast Neoplasms 7Lung Neoplasms 7Breast Neoplasms 7Ovarian Neoplasms 5Neoplasm Metastasis 5Endometrial Neoplasms 5Pancreatic Neoplasms 4Fallopian Tube Neoplasms 4Adenocarcinoma Of Esophagus 4Squamous Cell Carcinoma of Head and Neck 3Melanoma 3Esophageal Neoplasms 3Cholangiocarcinoma 3Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Brenner Tumor 2Anatomic Stage I Breast Cancer AJCC v8 2Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Sinonasal Squamous Cell Carcinoma 1Rectal Neoplasms 1Pancreatic Cystic Neoplasm 1Oropharyngeal Neoplasms 1Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Metastatic Pancreatic Ductal Adenocarcinoma 1Locally Advanced Cervical Adenocarcinoma 1

Interventions

Nivolumab 3Specimen Handling 2Magnetic Resonance Spectroscopy 2X-Rays 1Watchful Waiting 1Taxes 1Sigmoidoscopy 1Proctoscopy 1Phantoms, Imaging 1Paclitaxel 1Observation 1Ipilimumab 1Colonoscopy 1Carboplatin 1CTLA-4 Antigen 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anal Canal Carcinoma × Taxes × 30 days × Clear all
NCT04444921 2026-05-29

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

National Cancer Institute (NCI)

Phase 3 Active not recruiting
205 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡